To: Richard Nehrboss who wrote (44573 ) 1/26/1999 1:08:00 PM From: Peter Singleton Respond to of 132070
Richard, I haven't spent much time looking into this, but here are a couple of thoughts: 1 - There's no apples-to-apples comparison between ESOP shares and publicly traded securities. An ESOP share has the following characteristics: a - 10 year LEAP call at the price as of the day issued (what is that worth!?) b - vesting over a 4 year period (something on that order) c - claw-back provision for unvested shares upon ending employment for whatever reason d - favorable terms with respect to cash outlays upon exercise e - industry history of repricing options downward after steep share price decline 2 - Netting out the 5 factors above (dominated of course by the value of the effective 10 year LEAP call), the real value of the ESOP share grants each quarter has to be significant enough to render the reported earnings hugely overstated for most tech stocks, and effectively meaningless in terms of a value investor's ability to appraise real costs, revenues, earnings and cash flows. In other words, since the real earnings of these companies are a lot less than the reported earnings, the real P/E's are much higher than the reported P/E's. Net, net,the current, unreal, ahistorical valuations for tech stocks, are leveraged by an order of magnitude. And, ultimately, the real value of a share of a company, in the long-run, is a function of the risk-adjusted, discounted cash flows available to be assigned to the equity holder. Furthermore, *eventually*, the price will trend to this level ... and as high as it overshoots on the one hand, it may undershoot on the other. So, what does that mean? Will there be a hard reckoning? I suspect so, but my critical reasoning begins to shut down when I try to imagine a systemic response that would correct these asset prices. No joke. <ng> Peter